Y-mAbs Therapeutics, Inc. (YMAB) Earning

NASDAQ Currency in USD Disclaimer

$8.31

south_east -$0.27 (-3.09%)
Day's range
$8
Day's range
$8.47

Y-mAbs Therapeutics, Inc. Analyst EPS Estimates

Quarter Number of Estimates Low Estimate High Estimate Average Estimate
Q1 2024 3 -$0.16 -$0.12 -$0.14
Q2 2024 3 -$0.15 -$0.11 -$0.12
Q3 2024 3 -$0.19 -$0.14 -$0.16
Q4 2024 8 -$0.20 -$0.03 -$0.11
Q1 2025 4 -$0.21 -$0.04 -$0.15
Q2 2025 2 -$0.21 -$0.15 -$0.17
Q3 2025 2 -$0.20 -$0.15 -$0.17
Q4 2025 2 -$0.19 -$0.14 -$0.16

Y-mAbs Therapeutics, Inc. Earnings Date And Information

Y-mAbs Therapeutics, Inc. last posted its earnings results on Friday, November 8th, 2024. The company reported $-0.16 earnings per share for the quarter, missing analysts' consensus estimates of $-0.14 by $0.02. The company had revenue of 18.46 M for the quarter and had revenue of 84.82 M for the year. Y-mAbs Therapeutics, Inc. has generated $0 earnings per share over the last year ($-0.49 diluted earnings per share) and currently has a price-to-earnings ratio of -15.48. Y-mAbs Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based on prior year's report dates.

Y-mAbs Therapeutics, Inc. Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
11/08/2024 Q3 2024 -$0.14 -$0.16 -0.02 $23.28 M $18.46 M
08/12/2024 Q2 2024 -$0.21 $23.02 M $22.80 M
05/07/2024 Q1 2024 -$0.12 -$0.15 -0.03 $19.93 M
02/29/2024 Q4 2023 -$0.19 -$0.02 0.17 $23.36 M
11/13/2023 Q3 2023 -$0.16 -$0.18 -0.02 $20.97 M $20.45 M
08/10/2023 Q2 2023 -$0.24 -$0.14 0.1 $20.33 M $20.75 M
05/08/2023 Q1 2023 -$0.31 -$0.12 0.19 $20.25 M
03/30/2023 Q4 2022 -$0.44 -$0.01 0.43 $31.45 M
11/07/2022 Q3 2022 -$0.75 -$0.66 0.09 $12.01 M $12.54 M
08/08/2022 Q2 2022 -$0.68 -$0.97 -0.29 $11.23 M $10.80 M
05/09/2022 Q1 2022 -$0.71 -$0.65 0.06 $10.49 M
03/01/2022 Q4 2021 -$0.85 $9.60 M
11/04/2021 Q3 2021 -$0.60 -$0.66 -0.06 $10.87 M $8.97 M
08/09/2021 Q2 2021 -$0.53 $7.33 M $10.95 M
05/06/2021 Q1 2021 $0.61 $0.80 0.19 $5.38 M
03/01/2021 Q4 2020 -$0.48 $20.75 M
11/05/2020 Q3 2020 -$0.80 -$0.82 -0.02 $0
08/06/2020 Q2 2020 -$0.69 -$1.01 -0.32 $0
05/07/2020 Q1 2020 -$0.63 -$0.66 -0.03 $0
03/12/2020 Q4 2019 -$0.67 -$0.61 0.06 $0
 

Y-mAbs Therapeutics, Inc. Earnings: FAQ's

When is Y-mAbs Therapeutics, Inc.'s earnings date?

Y-mAbs Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based off last year's report dates.

How can I listen to Y-mAbs Therapeutics, Inc.'s earnings conference call?

The conference call for Y-mAbs Therapeutics, Inc.'s latest earnings report can be listened to online.

How can I read Y-mAbs Therapeutics, Inc.'s conference call transcript?

The conference call transcript for Y-mAbs Therapeutics, Inc.'s latest earnings report can be read online.

How much revenue does Y-mAbs Therapeutics, Inc. generate each year?

Y-mAbs Therapeutics, Inc. (:YMAB) has a recorded annual revenue of $84.82 M.

How much profit does Y-mAbs Therapeutics, Inc. generate each year?

Y-mAbs Therapeutics, Inc. (:YMAB) has a recorded net income of $84.82 M. Y-mAbs Therapeutics, Inc. has generated $-0.49 earnings per share over the last four quarters.

What is Y-mAbs Therapeutics, Inc.'s price-to-earnings ratio?

Y-mAbs Therapeutics, Inc. (:YMAB) has a price-to-earnings ratio of -15.48 and price/earnings-to-growth ratio is -4.34.

Portfolio Sync
Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED